Compare KE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KE | BVS |
|---|---|---|
| Founded | 1961 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.2M | 597.6M |
| IPO Year | 2014 | 2016 |
| Metric | KE | BVS |
|---|---|---|
| Price | $25.35 | $9.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $28.00 | $14.00 |
| AVG Volume (30 Days) | 120.4K | ★ 369.4K |
| Earning Date | 05-05-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | ★ 0.55 | 0.33 |
| Revenue | ★ $1,486,727,000.00 | $568,087,000.00 |
| Revenue This Year | N/A | $7.43 |
| Revenue Next Year | $4.57 | $6.61 |
| P/E Ratio | $46.09 | ★ $27.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.41 | $5.81 |
| 52 Week High | $33.19 | $9.56 |
| Indicator | KE | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.05 | 59.85 |
| Support Level | $23.38 | $7.04 |
| Resistance Level | $31.17 | $9.53 |
| Average True Range (ATR) | 1.03 | 0.34 |
| MACD | 0.40 | 0.02 |
| Stochastic Oscillator | 88.67 | 90.13 |
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.